Results 101 to 110 of about 369,301 (296)
Blau Syndrome (Juvenile Systemic Granulomatosis): State‐Of‐The‐Art Review
ABSTRACT Blau syndrome (BlauS) is a rare pediatric autoinflammatory disorder due to NOD2 gain‐of‐function pathogenic variants characterized by a triad of granulomatous dermatitis, arthritis, and uveitis, which can progress to systemic complications if untreated.
Ou Jia (Emilie) Wang+3 more
wiley +1 more source
Adjustment and Completion of BASNEF Model to Provide a New Model for Educating Large Populations in Relation to Cutaneous Leishmaniasis [PDF]
Background: Educational models that have been created for educating small populations do not have enough efficacy for educating large populations, so based on this premise and also high prevalence of Cutaneous Leishmaniasis (CL) in the Islamic Republic
Behravesh, O.+5 more
core
George Higoumenakis (1895-1983): Greek dermatologist [PDF]
This paper describes the Higoumenakis sign, enlargement of the sternal end of the clavicle in patients with late congenital syphilis and the dermatologist after whom it is named. Several professors and doctors from the Medical School of the University of
Frangos, CC, Frangos, CC
core +1 more source
There is a clear need for new strategies of leishmaniasis treatment. This work was conducted to evaluate the efficacy of the co‐administration of tamoxifen and meglumine antimoniate (SbV) in a phase II pilot clinical trial in localised cutaneous ...
P. Machado+9 more
semanticscholar +1 more source
In this study, we developed giant plasma membrane vesicles (GPMVs) from Leishmania amazonensis promastigote membranes to investigate the role of protein‐embedded membranes in methylene blue (MB) photooxidation. Upon MB photoactivation in model lipid membranes (giant unilamellar vesicles, GUVs), a distinct photooxidation effect was observed, marked by ...
Maressa D. F. de Souza+3 more
wiley +1 more source
Structures, targets and recent approaches in anti-leishmanial drug discovery and development. [PDF]
Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002.
Seifert, Karin
core +2 more sources
Multilesional cutaneous leishmaniasis [PDF]
A 27-year-old healthy woman presented to the medical centre with a one-month history of widespread skin lesions with slow clinical progression. The lesions appeared on her thighs, shins, lower abdomen and left arm three weeks after she had travelled to an area endemic for Leishmania major ...
Yuval Ramot, Abraham Zlotogorski
openaire +3 more sources
Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study*
BACKGROUND Pentavalent antimonials remain as the standard drugs in the treatment of cutaneous leishmaniosis. The high cost, difficult administration, long treatment time, toxicity and increasing morbidity are factors that limit the use of these drugs ...
S. V. C. B. Gonçalves, C. Costa
semanticscholar +1 more source
The Role of Foxes in Transmitting Zoonotic Bacteria to Humans: A Scoping Review
ABSTRACT Zoonotic diseases inflict substantial burdens on human and animal populations worldwide, and many of these infections are bacterial. An Australian study investigating environmental risk factors for Buruli ulcer in humans detected the causative agent, Mycobacterium ulcerans, in the faeces of wild foxes, a novel finding that suggests foxes may ...
Emma C. Hobbs+6 more
wiley +1 more source
Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa
The Syrian refugee crisis has precipitated a catastrophic outbreak of Old World cutaneous leishmaniasis now affecting hundreds of thousands of people living in refugee camps or trapped in conflict zones.
Rebecca Y Du+3 more
semanticscholar +1 more source